This compound is an antiviral pharmaceutical raw material supplied for manufacturing purposes. It consists of a tenofovir alafenamide-like prodrug moiety and fumaric acid forming a salt-like, multi-component structure.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1432630-26-6
Tenofovir isoproxil monoester
Pharmaceutical intermediate for tenofovir prodrug
(((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy)bis(methylene) isopropyl dicarbonate
Pharmaceutical intermediate
((2R,5S)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl 2-hydroxybenzoate
antiviral active pharmaceutical ingredient
Maribavir
antiviral active pharmaceutical ingredient
Baloxavir
antiviral active pharmaceutical ingredient
Favipiravir
antiviral active pharmaceutical ingredient
Eletriptan
active pharmaceutical ingredient
NARATRIPTAN HYDROCHLORIDE
active pharmaceutical ingredient
[[(2S)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid
VCMJCVGFSROFHV-KZHAMYRLSA-N
C[C@@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\C(=O)O